Anthelmintic Activity of Trikatu Churna and its Ingredients

The alcoholic extract of Trikatu churna and its ingredients were evaluated for anthelmintic activity. The dried fruits of Piper nigrum L. (Piperaceae), Piper longum L. (Piperaceae) and rhizome of Zingiber officinale Roscoe. (Zingiberaceae) were powdered and mixed together in equiproportions to get a polyherbal formulation, Trikatu churna. All these three ingredients are spicy, commonly used in our daily diet, also well known for their tremendous therapeutic potential, since from the Vedic period. The alcoholic extract of Trikatu churna and its ingredients were screened for preliminary phytochemical studies and also tested for anthelmintic activity against Pheritima posthuma and recorded the time taken for induction of paralysis and death. Piperazine citrate (10 mg/ml) was included as standard reference and distilled water as control. The results demonstrated that, the extracts of Trikatu churna and its plant ingredients showed the presence of alkaloids, flavonoids, tannins, lignins and steroids, these test samples were also exhibited potent anthelmintic activity, but the highest activity was noticed in Trikatu churna, this might be due to the multifunctional effect of all the three plant ingredients of Trikatu churna. Based on the above results, it is confirmed that, combination of Piper nigrum, Piper longum and Zingiber officinale in Trikatu churna offered promising anthelmintic effect than using the ingredients alone

Study on seasonal variation on the content of Cucurbitacin of various vegetative parts of Trichosanthes cucumerina L. var. cucumerina

The total cucurbitacin content produced in the different parts of T. cucumerina L. var. cucumerina viz., fruit, stem and leaves with time and temperature was studied during the year 2007-08. The highest amount of cucurbitacins was produced in the month of February, i.e., 0.8, 1.7 and 3.7 w/w % and lowest was in the month of July 1.9, 0.5 and 0.17 w/w % in fruit, stem and leaves respectively. Present study reviles that, Production of cucurbitacin is temperature dependent as the temperature increases cucurbitacins production increased; decrease in the temperature production of cucurbitacins was found decrease. Due to high content of cucurbitacins, this plant may prove itself as a potent hepatoprotective, anti-inflammatory, cytotoxic agent, antifeedant and antimicrobial properties of the plants.The stems are involved in the transportation of cucurbitacins but only the fruits are associated with storage. Although the leaves contained a low concentration of cucurbitacins or the role cucurbitacins is still important as antifeedants. For example, the bitterness of cucurbitacin E is experienced at a low concentration of 10 ppb [9] a concentration that is not detectable by quantitative methods used [26] determined cucurbitacin content in the fruit 40 times greater than in the leaves of Ecballium elaterium.[27] determined 22 times greater than that of the leaves. In present study considering the fresh plant material, the cucurbitacin content in the fruit is about 15 times greater than that of the leaves is adequate to promote and conduct various pharmacological activities, as hepatoprotective, anti-inflammatory, cytotoxic agent, antifeedant and antimicrobial [28] properties of the plants. This study reveals that production of cucurbitacins is temperature dependent (Figure-2), increase in temperature increases cucurbitacins and cucurbitacin E production.peer-reviewe

(2R*,3R*,4aS*,6aR*,11aS*,11bS*)-Methyl 2-acet­oxy-11b-hydr­oxy-3,7-dimethyl-1,2,3,4,4a,5,6,6a,7,11,11a,11b-dodeca­hydro­phenanthro[3,2-b]furan-3-carboxyl­ate

In the title compound, C22H30O6, the conformation of the mol­ecule is dictated by an intra­molecular C—H⋯O contact. The crystal structure is stabilized via inter­molecular C—H⋯O, O—H⋯O and C—H⋯π contacts

Phytochemical Studies of Strychnos potatorum

The present paper deals with the phytochemical screening of therapeutic importance from Strychnos potatorum L.f., an important medicinal plant. This study involves the preliminary screening, quantitative determination and the qualitative thin layer chromatographic separation of secondary metabolites from the root, stem bark and seeds (collected and market) of S.potatorum. Further, HPLC alkaloid profile of the seed has been studied. The generated data has provided the basis for its wide use as the therapeutant both in the traditional and folk medicines

Radiological Society of North America (RSNA) 3D Printing Special Interest Group (SIG) clinical situations for which 3D printing is considered an appropriate representation or extension of data contained in a medical imaging examination: breast conditions.

The use of medical 3D printing has expanded dramatically for breast diseases. A writing group composed of the Radiological Society of North America (RSNA) Special Interest Group on 3D Printing (SIG) provides updated appropriateness criteria for breast 3D printing in various clinical scenarios. Evidence-based appropriateness criteria are provided for the following clinical scenarios: benign breast lesions and high-risk breast lesions, breast cancer, breast reconstruction, and breast radiation (treatment planning and radiation delivery)

Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat

Vascular endothelial growth factor (VEGF) is recognized to play a predominant role in breast cancer prognosis. The action of VEGF is mediated by two high-affinity receptors with ligand-stimulated tyrosine kinase activity: VEGFR-1/flt-1 and VEGFR-2/flk-1, which are expressed mainly in vascular endothelial cells. To the best of our knowledge, no previous studies on the expression of these receptors in breast cancer cells has been made. We have established a new animal model for breast cancer, using a combination of 17β-oestradiol and testosterone as ‘carcinogens’. Taking advantage of the animal model, we have demonstrated that mammary cancer cells expressed not only high levels of VEGF but also, surprisingly, its receptors (flt-1 and flk-1) in mammary cancer cells. Intense reactivities to VEGF, flt-1 and flk-1 were observed in mammary cancer cells, especially in invasive mammary carcinoma. Western blot analysis confirmed the increase in flk-1 and flt-1 proteins in induced mammary cancers. Based on these observations, we hypothesize that in mammary cancer, VEGF regulates, in addition to endothelial proliferation and angiogenesis, also growth of cancer cells by an autocrine mechanism mediated through its receptors. To further verify this hypothesis, we investigated the correlation between cellular proliferation and the expression of VEGF, flt-1 and flk-1. Using double-labelling immunocytochemistry, we have shown a correlation between high VEGF activity and Ki-67 expression. The Ki-67 indices in the areas of strong and weak VEGF reactivities were 58.3% and 3.7% respectively. Similarly, there was also a correlation of strong flk-1 and Ki-67 reactivity. The Ki-67 indices for areas of strong and weak flk-1 reactivities were 53.9% and 3.1% respectively. On the other hand, there was a reverse correlation between flt-1 and Ki-67 activities. These results indicate that overexpression of VEGF and flk-1 is correlated with high Ki-67 index. The data, therefore, suggest that VEGF may act as an autocrine growth factor for mammary cancer cells in vivo and this autocrine regulatory role may be mediated through flk-1. The present study is the first report showing that VEGF may act as a growth stimulator for mammary cancer cells. © 1999 Cancer Research Campaig

The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis

VEGF-A activity is tightly regulated by ligand and receptor availability. Here we investigate the physiological function of heterodimers between VEGF receptor-1 (VEGFR-1; Flt-1) and VEGFR-2 (KDR; Flk-1) (VEGFR(1-2)) in endothelial cells with a synthetic ligand that binds specifically to VEGFR(1-2). The dimeric ligand comprises one VEGFR-2-specific monomer (VEGF-E) and a VEGFR-1-specific monomer (PlGF-1). Here we show that VEGFR(1-2) activation mediates VEGFR phosphorylation, endothelial cell migration, sustained in vitro tube formation and vasorelaxation via the nitric oxide pathway. VEGFR(1-2) activation does not mediate proliferation or elicit endothelial tissue factor production, confirming that these functions are controlled by VEGFR-2 homodimers. We further demonstrate that activation of VEGFR(1-2) inhibits VEGF-A-induced prostacyclin release, phosphorylation of ERK1/2 MAP kinase and mobilization of intracellular calcium from primary endothelial cells. These findings indicate that VEGFR-1 subunits modulate VEGF activity predominantly by forming heterodimer receptors with VEGFR-2 subunits and such heterodimers regulate endothelial cell homeostasis

An update on vitamin B12-related gene polymorphisms and B12 status.

Vitamin B12 is an essential micronutrient in humans needed for health maintenance. Deficiency of vitamin B12 has been linked to dietary, environmental and genetic factors. Evidence for the genetic basis of vitamin B12 status is poorly understood. However, advancements in genomic techniques have increased the knowledge-base of the genetics of vitamin B12 status. Based on the candidate gene and genome-wide association (GWA) studies, associations between genetic loci in several genes involved in vitamin B12 metabolism have been identified. The objective of this literature review was to identify and discuss reports of associations between single-nucleotide polymorphisms (SNPs) in vitamin B12 pathway genes and their influence on the circulating levels of vitamin B12. Relevant articles were obtained through a literature search on PubMed through to May 2017. An article was included if it examined an association of a SNP with serum or plasma vitamin B12 concentration. Beta coefficients and odds ratios were used to describe the strength of an association, and a  < 0.05 was considered as statistically significant. Two reviewers independently evaluated the eligibility for the inclusion criteria and extracted the data. From 23 studies which fulfilled the selection criteria, 16 studies identified SNPs that showed statistically significant associations with vitamin B12 concentrations. Fifty-nine vitamin B12-related gene polymorphisms associated with vitamin B12 status were identified in total, from the following populations: African American, Brazilian, Canadian, Chinese, Danish, English, European ancestry, Icelandic, Indian, Italian, Latino, Northern Irish, Portuguese and residents of the USA. Overall, the data analyzed suggests that ethnic-specific associations are involved in the genetic determination of vitamin B12 concentrations. However, despite recent success in genetic studies, the majority of identified genes that could explain variation in vitamin B12 concentrations were from Caucasian populations. Further research utilizing larger sample sizes of non-Caucasian populations is necessary in order to better understand these ethnic-specific associations